Acurex Biosciences Corporation

Acurex Biosciences Receives U.S. Composition-of-Matter Patent for CU-00048, a Potential Best-in-Class T-Type Calcium Channel Antagonist for Essential Tremor

Patent protects CU-00048 into 2042 as T-type calcium channel antagonists near their first FDA decision in Essential Tremor SAN CARLOS, Calif., Oct.…